A paired-image radiation transport model for skeletal dosimetry

Journal of Nuclear Medicine

Volumn 46, Issue 2, 2005, Pages 344-353

  Shah, Amish P ^a   Bolch, Wesley E ^a   Rajon, Didier A ^b   Patton, Phillip W ^c   Jokisch, Derek W ^d  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d FRANCIS MARION UNIVERSITY   (United States)

Author keywords

Absorbed fraction; Marrow dose; Nuclear magnetic resonance microscopy; Radionuclide S value; Skeletal dosimetry

Indexed keywords

ERBIUM 169; LUTETIUM 177; PHOSPHORUS 32; PHOSPHORUS 33; RADIOISOTOPE; RHENIUM 186; RHENIUM 188; SAMARIUM 153; STRONTIUM 89; YTTRIUM 90;

ARTICLE; BONE MARROW; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DOSIMETRY; FEMUR; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LUMBAR VERTEBRA; MALE; MICROSCOPY; MODEL; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE MICROSCOPY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE DISTRIBUTION; TRABECULAR BONE; AGED; ALGORITHM; BIOLOGICAL MODEL; BODY BURDEN; BONE; CADAVER; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; EVALUATION; IMAGE SUBTRACTION; LINEAR ENERGY TRANSFER; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIOGRAPHY; RADIOMETRY; RELATIVE BIOLOGIC EFFECTIVENESS;

AGED; ALGORITHMS; BODY BURDEN; BONE AND BONES; CADAVER; COMPUTER SIMULATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR ENERGY TRANSFER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RELATIVE BIOLOGICAL EFFECTIVENESS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 15844412645     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Spiers FW. Radiotherapeutic physics. II. Dosage in irradiated soft tissue and bone. Br J Radiol. 1951;24:365-370.
2. Spiers FW. Dose to trabecular bone from internal beta-emitters. In: Snyder WS, ed. First International Congress of Radiation Protection. Vol. 1. Rome, Italy: Pergamon Press; 1966:165-172.
3. Spiers FW. A review of the theoretical and experimental methods of determining radiation dose in bone. Br J Radiol. 1966;39:216-221.
4. Spiers FW. Beta particle dosimetry in trabecular bone. In: Mays CW, Jee WSS, Lloyd RD, Stover BJ, Dougherty JH, Taylor GN, eds. Delayed Effects of Bone-Seeking Radionuclides. Salt Lake City, UT: University of Utah Press; 1967:95-108.
5. Spiers FW. Dosimetry at interfaces with special reference to bone. In: Booz J, Ebert HG, eds. Symposium on Microdosimetry. Report EUR 3747. Ispra, Italy: European Atomic Energy Commission; 1968:473-508.
6. Spiers FW. Determination of absorbed dose to bone and red bone marrow. In: Cloutier R, Edwards C, Snyder W, eds. Medical Radionuclides: Radiation Dose and Effects. AEC Symposium Series 20. Oak Ridge, TN: U.S. Atomic Energy Commission; 1969:347-367.
7. Beddoe AH. The Microstructure of Mammalian Bone in Relation to the Dosimetry of Bone-Seeking Radionuclides [thesis]. Leeds, U.K.: Department of Medical Physics, University of Leeds; 1976.
8. Beddoe AH, Darley PJ, Spiers FW. Measurements of trabecular bone structure in man. Phys Med Biol. 1976;21:589-607.
9. Whitwell JR. Theoretical Investigations of Energy Loss by Ionizing Particles in Bone [thesis]. Leeds, U.K.: Department of Medical Physics, University of Leeds; 1973.
10. Whitwell JR, Spiers FW. Calculated beta-ray dose factors for trabecular bone. Phys Med Biol. 1976;21:16-38.
11. ICRP. Report on the Task Group on Reference Man. ICRP Publication 23. Oxford, UK: International Commission on Radiological Protection; 1975:62-98.
12. ICRP. Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values. Publication 89. New York, NY: International Commission on Radiological Protection; 2002:167-190.
13. Eckerman KF. Aspects of the dosimetry of radionuclides within the skeleton with particular emphasis on the active marrow. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of the Fourth International Radiopharmaceutical Dosimetry Symposium. CONF-85113. Oak Ridge, TN: Oak Ridge Associated Universities; 1985:514-534.
14. Bouchet LG, Bolch WE, Howell RW, Rao DV. S values for radionuclides localized within the skeleton. J Nucl Med. 2000;41:189-212.
15. Bouchet LG, Jokisch DW, Bolch WE. A three-dimensional transport model for determining absorbed fractions of energy for electrons in trabecular bone. J Nucl Med. 1999;40:1947-1966.
16. Eckerman KF, Stabin MG. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. Health Phys. 2000;78:199-214.
17. Stabin MG, Eckerman KF, Bolch WE, Bouchet LG, Patton PW. Evolution and status of bone and marrow dose models. Cancer Biother Radiopharm. 2002;17: 427-445.
18. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538-546.
19. Patton PW, Rajon DA, Shah AP, Jokisch DW, Inglis B, Bolch WE. Site-specific variability in trabecular bone dosimetry: considerations of energy loss to cortical bone. Med Phys. 2002;29:6-14.
20. Jokisch DW, Bouchet LG, Patton PW, Rajon DA. Bolch WE. Beta-particle dosimetry of the trabecular skeleton using Monte Carlo transport within 3D digital images. Med Phys. 2001;28:1505-1518.
21. Nipper J, Williams J, Bolch W. Creation of two tomographic voxel models of pediatric patients in the first year of life. Phys Med Biol. 2002;47:3143-3164.
22. Kawrakow I. Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Med Phys. 2000;27:485-498.
23. Briesmeister JF. MCNP: A General Monte Carlo N-Particle Transport Code. LA-12625-M. Los Alamos, NM: Los Alamos National Laboratory; 1997.
24. Patton PW, Jokisch DW, Rajon DA, Shah AP, Myers SL, Bolch WE. Skeletal dosimetry via NMR microscopy: investigations of sample reproducibility and signal source. Health Phys. 2002;82:316-326.
25. Shah AP, Patton PW, Rajon DA, Bolch WE. Adipocyte spatial distributions in bone marrow: implications for skeletal dosimetry models. J Nucl Med. 2003;44: 774-783.
26. Bolch WE, Patton PW, Shah AP, Rajon DA. Considerations of anthropomorphic, tissue volume, and tissue mass scaling for improved patient specificity of skeletal S values. Med Phys. 2002;29:1054-1070.
27. Bolch WE, Patton PW, Rajon DA, Shah AP, Jokisch DW, Inglis B. Considerations of marrow cellularity in 3D dosimetric models of the trabecular skeleton. J Nucl Med. 2002;43:97-108.
28. Jokisch DW, Patton PW, Inglis BA, et al. NMR microscopy of trabecular bone and its role in skeletal dosimetry. Health Phys. 1998;75:584-596.
29. Jokisch DW, Patton PW, Rajon DA, Inglis BA, Bolch WE. Chord distributions across 3D digital images of a human thoracic vertebra. Med Phys. 2001;28:1493-1504.
30. ICRU. Photon, Electron, Proton and Neutron Interaction Data for Body Tissues. Report 46. Bethesda, MD: International Commission on Radiation Units and Measurements; 1992.
31. ICRP. Basic Anatomical and Physiological Data for Use in Radiological Protection: The Skeleton. ICRP Publication 70. Oxford, U.K.: International Commission on Radiological Protection; 1995:1-80.
32. Eckerman KF, Westfall RJ, Ryman JC, Cristy M. Availability of nuclear decay data in electronic form, including beta spectra not previously published. Health Phys. 1994;67:338-345.
33. Turner H, Claringbold P. A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153-EDTMP. Eur J Cancer. 1991;27:1084-1086.
34. Collins C, Eary JF, Donaldson G, et al. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med. 1993;34:1839-1844.
35. Farhanghi M, Holmes RA, Volkert WA, Logan KW, Singh A. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J Nucl Med. 1992;33:1451-1458.
36. Kucuk NO, Ibis E, Aras G, et al. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Ann Nucl Med. 2000;14:239-245.
37. Giannakenas C, Kalofonos HP, Apostolopoulos DJ, Zarakovitis J, Kosmas C, Vassilakos PJ. Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone disease. Am J Clin Oncol. 2000;23:83-88.
38. Breitz HB, Fisher DR, Wessels BW. Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody. J Nucl Med. 1998;39: 1746-1751.
39. van Rensburg AJ, Alberts AS, Louw WK. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP. J Nucl Med. 1998;39:2110-2115.
40. 153Sm-EDTMP in patients with metastatic bone disease. J Nucl Med. 2001;42:230-236.